256 related articles for article (PubMed ID: 24493131)
1. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.
Garg AD; Agostinis P
Photochem Photobiol Sci; 2014 Mar; 13(3):474-87. PubMed ID: 24493131
[TBL] [Abstract][Full Text] [Related]
2. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum-targeting photosensitizer Hypericin confers chemo-sensitization towards oxaliplatin through inducing pro-death autophagy.
Lin S; Yang L; Shi H; Du W; Qi Y; Qiu C; Liang X; Shi W; Liu J
Int J Biochem Cell Biol; 2017 Jun; 87():54-68. PubMed ID: 28392376
[TBL] [Abstract][Full Text] [Related]
4. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
[TBL] [Abstract][Full Text] [Related]
5. Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage.
Yu TT; Hu J; Li QR; Peng XC; Xu HZ; Han N; Li LG; Yang XX; Xu X; Yang ZY; Chen H; Chen X; Wang MF; Li TF
Int Immunopharmacol; 2023 Feb; 115():109661. PubMed ID: 36608440
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q
ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527
[TBL] [Abstract][Full Text] [Related]
7. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.
Turubanova VD; Mishchenko TA; Balalaeva IV; Efimova I; Peskova NN; Klapshina LG; Lermontova SA; Bachert C; Krysko O; Vedunova MV; Krysko DV
Sci Rep; 2021 Mar; 11(1):7205. PubMed ID: 33785775
[TBL] [Abstract][Full Text] [Related]
8. Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy.
Garg AD; Maes H; Romano E; Agostinis P
Photochem Photobiol Sci; 2015 Aug; 14(8):1410-24. PubMed ID: 25666525
[TBL] [Abstract][Full Text] [Related]
9. Molecular response to hypericin-induced photodamage.
Krammer B; Verwanger T
Curr Med Chem; 2012; 19(6):793-8. PubMed ID: 22214453
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of phenanthroperylenequinones in photodynamic therapy (review).
Ali SM; Olivo M
Int J Oncol; 2003 Jun; 22(6):1181-91. PubMed ID: 12738982
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
[TBL] [Abstract][Full Text] [Related]
12. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
Mikešová L; Mikeš J; Kovaľ J; Gyurászová K; Culka L; Vargová J; Valeková B; Fedoročko P
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
[TBL] [Abstract][Full Text] [Related]
13. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
14. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.
Garg AD; Nowis D; Golab J; Agostinis P
Apoptosis; 2010 Sep; 15(9):1050-71. PubMed ID: 20221698
[TBL] [Abstract][Full Text] [Related]
16. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.
Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631
[TBL] [Abstract][Full Text] [Related]
17. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
18. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy.
Davids LM; Kleemann B; Cooper S; Kidson SH
Cell Biol Int; 2009 Oct; 33(10):1065-72. PubMed ID: 19596456
[TBL] [Abstract][Full Text] [Related]
19. Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity.
Donohoe C; Senge MO; Arnaut LG; Gomes-da-Silva LC
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188308. PubMed ID: 31401103
[TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
Popovic A; Wiggins T; Davids LM
J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
